Parshall B. Lynne's most recent trade in Cytokinetics Inc was a trade of 5,000 Common Stock done at an average price of $71.5 . Disclosure was reported to the exchange on Sept. 1, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 71.48 per share. | 01 Sep 2026 | 5,000 | 10,784 (0%) | 0% | 71.5 | 357,400 | Common Stock |
| Foghorn Therapeutics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 24 Jun 2026 | 28,000 | 28,000 | - | - | Stock Options (Right to buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 74.08 per share. | 01 Jun 2026 | 5,000 | 15,784 (0%) | 0% | 74.1 | 370,400 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 27 May 2026 | 4,301 | 4,301 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 May 2026 | 2,851 | 20,784 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 76.19 per share. | 15 Apr 2026 | 4,466 | 51,878 (0%) | 0% | 76.2 | 340,265 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 76.19 per share. | 15 Apr 2026 | 4,466 | 51,878 (0%) | 0% | 76.2 | 340,265 | - |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 76.97 per share. | 15 Apr 2026 | 534 | 51,344 (0%) | 0% | 77.0 | 41,102 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 76.97 per share. | 15 Apr 2026 | 534 | 51,344 (0%) | 0% | 77.0 | 41,102 | - |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 61.21 per share. | 02 Mar 2026 | 5,000 | 17,933 (0%) | 0% | 61.2 | 306,050 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 61.21 per share. | 02 Mar 2026 | 5,000 | 17,933 (0%) | 0% | 61.2 | 306,050 | - |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 61.21 per share. | 02 Mar 2026 | 5,000 | 17,933 (0%) | 0% | 61.2 | 306,050 | - |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 82.72 per share. | 11 Feb 2026 | 5,000 | 56,344 (0%) | 0% | 82.7 | 413,589 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 82.72 per share. | 11 Feb 2026 | 5,000 | 56,344 (0%) | 0% | 82.7 | 413,589 | - |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 64.73 per share. | 19 Nov 2025 | 5,000 | 22,933 (0%) | 0% | 64.7 | 323,650 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 64.73 per share. | 19 Nov 2025 | 5,000 | 22,933 (0%) | 0% | 64.7 | 323,650 | - |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 64.73 per share. | 19 Nov 2025 | 5,000 | 22,933 (0%) | 0% | 64.7 | 323,650 | - |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 71.74 per share. | 15 Oct 2025 | 5,000 | 61,344 (0%) | 0% | 71.7 | 358,722 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 50.42 per share. | 02 Sep 2025 | 10,750 | 75,594 (0%) | 0% | 50.4 | 542,015 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 51.49 per share. | 02 Sep 2025 | 9,250 | 66,344 (0%) | 0% | 51.5 | 476,283 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 41.87 per share. | 06 Aug 2025 | 4,600 | 86,744 (0%) | 0% | 41.9 | 192,595 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 42.63 per share. | 06 Aug 2025 | 400 | 86,344 (0%) | 0% | 42.6 | 17,051 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2025 | 4,079 | 91,344 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 15 Jul 2025 | 4,079 | 5,220 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Jul 2025 | 11,518 | 11,518 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Jul 2025 | 5,220 | 9,299 | - | - | Restricted Stock Unit | ||
| Foghorn Therapeutics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 17 Jun 2025 | 25,000 | 25,000 | - | - | Stock Option (right to buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 14 May 2025 | 10,880 | 10,880 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 7,333 | 27,933 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 7,333 | 27,933 (0%) | 0% | 0 | - | |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2025 | 7,333 | 27,933 (0%) | 0% | 0 | - | |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.61 per share. | 09 Sep 2024 | 5,000 | 25,600 (0%) | 0% | 21.6 | 108,050 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 09 Sep 2024 | 5,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 54.92 per share. | 09 Sep 2024 | 5,000 | 20,600 (0%) | 0% | 54.9 | 274,600 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.61 per share. | 26 Aug 2024 | 5,000 | 25,600 (0%) | 0% | 21.6 | 108,050 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 26 Aug 2024 | 5,000 | 5,000 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 57.26 per share. | 26 Aug 2024 | 5,000 | 20,600 (0%) | 0% | 57.3 | 286,300 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 55.20 per share. | 12 Aug 2024 | 5,000 | 20,600 (0%) | 0% | 55.2 | 276,000 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.61 per share. | 12 Aug 2024 | 5,000 | 25,600 (0%) | 0% | 21.6 | 108,050 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 12 Aug 2024 | 5,000 | 10,000 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 59.84 per share. | 29 Jul 2024 | 5,000 | 20,600 (0%) | 0% | 59.8 | 299,200 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 29 Jul 2024 | 5,000 | 15,000 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 21.61 per share. | 29 Jul 2024 | 5,000 | 25,600 (0%) | 0% | 21.6 | 108,050 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 55.82 per share. | 15 Jul 2024 | 5,000 | 20,600 (0%) | 0% | 55.8 | 279,100 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.68 per share. | 15 Jul 2024 | 5,000 | 25,600 (0%) | 0% | 10.7 | 53,400 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 15 Jul 2024 | 5,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 15 Jul 2024 | 4,677 | 4,079 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2024 | 4,677 | 87,265 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Jul 2024 | 10,111 | 10,111 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Jul 2024 | 5,000 | 5,000 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 54.22 per share. | 01 Jul 2024 | 5,000 | 20,600 (0%) | 0% | 54.2 | 271,100 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.68 per share. | 01 Jul 2024 | 5,000 | 25,600 (0%) | 0% | 10.7 | 53,400 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Jul 2024 | 4,079 | 8,756 | - | - | Restricted Stock Unit | ||
| Foghorn Therapeutics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 26 Jun 2024 | 16,000 | 16,000 | - | - | Stock Options (Right to buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.68 per share. | 17 Jun 2024 | 5,000 | 25,600 (0%) | 0% | 10.7 | 53,400 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 17 Jun 2024 | 5,000 | 10,000 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 52.55 per share. | 17 Jun 2024 | 5,000 | 20,600 (0%) | 0% | 52.6 | 262,750 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 03 Jun 2024 | 5,000 | 15,000 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 48.64 per share. | 03 Jun 2024 | 5,000 | 15,600 (0%) | 0% | 48.6 | 243,200 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 10.68 per share. | 03 Jun 2024 | 5,000 | 20,600 (0%) | 0% | 10.7 | 53,400 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 5,600 | 20,600 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 15 May 2024 | 3,636 | 3,636 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 50.23 per share. | 26 Dec 2023 | 50,000 | 82,588 (0%) | 0% | 50.2 | 2,511,515 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 26 Dec 2023 | 50,000 | 42,525 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.34 per share. | 26 Dec 2023 | 50,000 | 132,588 (0%) | 0% | 47.3 | 2,367,000 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.34 per share. | 26 Dec 2023 | 42,525 | 125,113 (0%) | 0% | 47.3 | 2,013,134 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 50.19 per share. | 26 Dec 2023 | 42,525 | 82,588 (0%) | 0% | 50.2 | 2,134,223 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 26 Dec 2023 | 42,525 | 0 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 47.34 per share. | 26 Dec 2023 | 25,113 | 107,701 (0%) | 0% | 47.3 | 1,188,849 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 26 Dec 2023 | 25,113 | 92,525 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 51.46 per share. | 26 Dec 2023 | 25,113 | 82,588 (0%) | 0% | 51.5 | 1,292,390 | Common Stock |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 45.13 per share. | 26 Sep 2023 | 10,000 | 82,588 (0%) | 0% | 45.1 | 451,268 | - |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 17 Jul 2023 | 5,333 | 4,677 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 5,333 | 92,588 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Jul 2023 | 1,777 | 87,255 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 17 Jul 2023 | 1,777 | 10,010 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 03 Jul 2023 | 10,321 | 10,321 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 03 Jul 2023 | 4,677 | 11,787 | - | - | Restricted Stock Unit | ||
| Foghorn Therapeutics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 21 Jun 2023 | 16,000 | 16,000 | - | - | Stock Option (right to buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 10 May 2023 | 10,000 | 10,000 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2023 | 5,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Sale of securities on an exchange or to another person at price $ 52.79 per share. | 01 Sep 2022 | 30,296 | 10,000 (0%) | 0% | 52.8 | 1,599,326 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 9.45 per share. | 01 Sep 2022 | 20,000 | 35,714 (0%) | 0% | 9.5 | 189,000 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Sep 2022 | 20,000 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Sep 2022 | 5,714 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 8.75 per share. | 01 Sep 2022 | 5,714 | 15,714 (0%) | 0% | 8.8 | 49,998 | Common Stock |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Sep 2022 | 4,582 | 0 | - | - | Non-Qualified Stock Option (Right to Buy) | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.82 per share. | 01 Sep 2022 | 4,582 | 40,296 (0%) | 0% | 6.8 | 31,249 | Common Stock |
| Foghorn Therapeutics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 16 Aug 2022 | 32,000 | 32,000 | - | - | Stock Options (Right to buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 15 Jul 2022 | 5,333 | 9,775 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 5,333 | 82,813 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Jul 2022 | 2,665 | 85,478 (0%) | 0% | 0 | Common Stock | |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 15 Jul 2022 | 2,665 | 7,110 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Jul 2022 | 12,000 | 12,000 | - | - | Non-Qualified Stock Option (right to buy) | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 01 Jul 2022 | 5,333 | 15,108 | - | - | Restricted Stock Unit | ||
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 5,000 | 10,000 (0%) | 0% | 0 | - | |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 5,000 | 10,000 (0%) | 0% | 0 | - | |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 5,000 | 10,000 (0%) | 0% | 0 | - | |
| Cytokinetics Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 May 2022 | 5,000 | 10,000 (0%) | 0% | 0 | - | |
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | 18 Jan 2022 | 5,754 | 9,775 | - | - | Restricted Stock Unit | ||
| Ionis Pharma Inc | Ms. B. Lynne Parshall, Esq.,J.D. | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 5,754 | 79,132 (0%) | 0% | 0 | Common Stock |